A case report of immunotherapy-related breast reactive capillary endothelial proliferation
Reactive capillary endothelial proliferation (RCEP) is the most common immune-related adverse event (irAE) during Camrelizumab treatment. RCEP occurs in the majority of patients with advanced solid tumors who receive Camrelizumab monotherapy. This irAE mainly occurs in the skin clinically, and RCEP...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Chinês |
| Опубликовано: |
Editorial Office of New Medicine
2023-02-01
|
| Серии: | Yixue xinzhi zazhi |
| Предметы: | |
| Online-ссылка: | https://yxxz.whuznhmedj.com/futureApi/storage/attach/2302/XxOqFquz1qmFfjHsPR3gIrZjMjcRug5Zp5O0CZd7.pdf |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|